Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

157.20
Delayed Data
As of Feb 27
 +0.25 / +0.16%
Today’s Change
86.00
Today|||52-Week Range
172.98
+36.77%
Year-to-Date
Top 10 News for 2/23 - 2/27: Revised GDP Slips, but Beats, in Q4; Two Pharma Giants t...
Feb 27 / Investing Channel
Jim Cramer: Dollar General's Sales Accelerate, Valeant Is Undervalued
Feb 23 / TheStreet.com
Whobs Next In The Pharma Buyout Boom?
Feb 26 / Investing Channel
Morning Market Gainers
Feb 23 / Benzinga
Pharmacyclics considers $19bn sale
Feb 25 / FT.com
Notable Mergers and Acquisitions 2/23: (VRX)/(SLXP) (MMM)/(PPO) (AIR)/(TDG) (OCN)/(NS...
Feb 23 / Investing Channel
Notable Downgrades: Rosetta Resources (ROSE), American Airlines (AAL), St. Jude Medic...
Feb 24 / Investing Channel
Fed in Focus This Week - Ahead of Wall Street
Feb 23 / Zacks.com
Salix Pharmaceuticals (SLXP) Stock Price Target Increased Today at Cantor Fitzgerald
Feb 24 / TheStreet.com
Stock Futures Are Mixed Following a Record-Breaking Rally
Feb 23 / TheStreet.com
Stock Market News for February 24, 2015 - Market News
Feb 24 / Zacks.com
US Stock Futures Slip Ahead Of Economic Data
Feb 23 / Benzinga
Pharma ETFs in Focus on Valeant-Salix Deal - ETF News And Commentary
Feb 24 / Zacks.com
Frontrunning: February 23
Feb 23 / Investing Channel
Jim Cramer Says Investors Should Buy Valeant Pharmaceuticals (VRX) After It Acquired ...
Feb 24 / TheStreet.com
Greek Government Under Fire at Home
Feb 23 / TheStreet.com
Valeant Pharma (VRX) Soars on Salix Buy: 3 Keys for Investors - Stocks in the News
Feb 23 / Zacks.com
Greek Government Under Fire at Home
Feb 23 / TheStreet.com
Biotech Stocks Moving Higher
Feb 23 / Benzinga
Must Watch Stocks for Today
Feb 23 / Benzinga
Fast Money Halftime Report Final Trade From February 23
Feb 23 / Benzinga
Fast Money Halftime Report Final Trade From February 20
Feb 22 / Benzinga
Valeant CEO Explains Why The Company Is Acquiring Salix For $10.1 Billion Cash Instea...
Feb 23 / Benzinga
Valeant Agrees to Buy Salix Pharma for $14.5 Billion in Cash
Feb 22 / TheStreet.com
Notable Downgrades: Transocean Ltd. (RIG), Polypore (PPO), Home Loan Servicing Soluti...
Feb 23 / Investing Channel
Benzinga's Weekend M&A Chatter
Feb 22 / Benzinga
Valeant shares surge 13% on Salix deal
Feb 23 / FT.com
Valeant agrees to buy Salix for nearly $10bn
Feb 22 / FT.com
Valeant/Salix: at what cost
Feb 23 / FT.com
Valeant (VRX) to Buy Salix Pharmaceuticals (SLXP) for $10.1Billion: Report
Feb 22 / Investing Channel
Why Valeant Pharmaceuticals Int'l Inc.'s Shares Took Off Today
Feb 23 / MotleyFool.com
Valeant nears deal to buy Salix
Feb 21 / FT.com
Energy stocks retreat after crude declines
Feb 23 / FT.com
Oncolytics Biotech Completes Enrolment for Reolysin Study - Analyst Blog
Feb 19 / Zacks.com
Valeant Surges on Salix Acquisition: What Wall Street's Saying
Feb 23 / TheStreet.com
Celsus Plunges on Dismal Dermatology Drug Study Results - Analyst Blog
Feb 18 / Zacks.com
Cramer: Valeant's Stock Doesn't Stop Here, It Goes Higher
Feb 23 / Benzinga
Ignyta's Lead Drug Gets Orphan Status for Colorectal Cancer - Analyst Blog
Feb 18 / Zacks.com
Benzinga's Volume Movers
Feb 23 / Benzinga
Pfizer NDA on Pain Management Candidate Accepted by FDA - Analyst Blog
Feb 17 / Zacks.com

To view my watchlist

Not a member yet?

Sign up now for a free account